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The work outlined in this dissertation will allow biochemists and cellular 
biologists to characterize polyubiquitin chains involved in their cellular environment 
by following a facile mass spectrometric based workflow. The characterization of 
polyubiquitin chains has been of interest since their discovery in 1984. The profound 
effects of ubiquitination on the movement and processing of cellular proteins depend 
exclusively on the structures of mono and polyubiquitin modifications anchored or 
unanchored on the protein within the cellular environment. However, structure-
function studies have been hindered by the difficulty in identifying complex chain 
structures due to limited instrument capabilities of the past.  
Genetic mutations or reiterative immunoprecipitations have been used 
previously to characterize the polyubiquitin chains, but their tedium makes it difficult 
to study a broad ubiquitinome. Top-down and middle-out mass spectral based 
  
proteomic studies have been reported for polyubiquitin and have had success in 
characterizing parts of the chain, but no method to date has been successful at 
differentiating all theoretical ubiquitin chain isomers (ubiquitin chain lengths from 
dimer to tetramer alone have 1340 possible isomers). The workflow presented here 
can identify chain length, topology and linkages present using a chromatographic-
time-scale compatible, LC-MS/MS based workflow.  
  To accomplish this feat, the strategy had to exploit the most recent advances 
in top-down mass spectrometry. This included the most advanced electron transfer 
dissociation (ETD) activation and sensitivity for large masses from the orbitrap 
Fusion Lumos. The spectral interpretation had to be done manually with the aid of a 
graphical interface to assign mass shifts because of a lack of software capable to 
interpret fragmentation across isopeptide linkages. However, the method outlined can 
be applied to any mass spectral based system granted it results in extensive 
fragmentation across the polyubiquitin chain; making this method adaptable to future 
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Ubiquitin (Ub) is a 76 amino acid protein that is found ubiquitously in 
eukaryotic cells, hence its name. There are also many Ub-like (UbL) proteins in a 
range of eukaryotic cell types including Rub1 (AKA Nedd8 in mammals)1 and 
SUMO,2 which have complimentary, but different sequences and functions compared 
to Ub.3 Prokaryotes are also known to carry a UbL, called ThiS, which has been 
shown to have similar functions to Ub.4 The fact that Ub and its sequence are so 
highly conserved suggests its importance for cellular proliferation.5 
The alteration of a protein after it has been translated is called a post 
translational modification (PTM). Ub can be attached to proteins, including itself, as a 
PTM, through the formation of an isopeptide bond between its carboxyl terminus 
(G76) and the ε-amine of a lysine (K) residue or the N-terminus of the initial 






Figure 1.1. Human ubiquitin sequence, which contains 76 amino acid residues. All 





Ubiquitination can occur in different ways: a single Ub can be attached at a 
single site (monoubiquitination) (Figure 1.2a) or multiple sites (multiubiquitination), 
(Figure 1.2b) or a chain of internally linked Ub can be anchored to a protein 
(polyubiquitination.) (Figure 1.2d) Various polyUbs are also present in the cell 
unanchored (Figure 1.2c). The possible linkage sites for intra Ub chain formation are 
M1, K6, K11, K27, K29, K33, K48, and K63 (highlighted in cyan in Figure 1.1). 
PolyUb is difficult to characterize because a single Ub chain can be made of all one 
linkage type (homotypic) (Figure 1.2c) or different linkages (mixed) (Figure 1.2d)7 It 
is even possible -and seen in vivo- to have a branched polyUb;8 a Ub with multiple 
isopeptide linked Ubs attached (Figure 1.2e). Thus the potential intracellular 






Figure 1.2. The many types of ubiquitination laid out in ball-and-stick models. 
Monoubiquitination (single: a. and multi: b.) and polyubiquitination (homotypic: c., 
heterotypic: d., and branched: e.) are shown anchored (a., b., and c.) and unanchored 
(c. and e.) to a substrate protein. 
 
 
Anchored and unanchored chains have been known to play a major role in 
DNA repair,9 protein degradation,5,10 cancer morphology,11 protein kinase activity,12 
redox regulation,13 and aggresome degradation.14 This myriad of cellular responses is 




shape and linkages present (Figure 1.3)15 and yet, characterization and quantification 
of the ubiquitinome has been limited.7,16 Current characterization techniques do not 
allow for the full identification of the different possible structures and linkages of 
polyUb, thus limiting the information cellular biologists can obtain about the function 





Figure 1.3. Outline of the different linkages and shapes of polyUb and their known 




 The scientific community has developed a few methods for identification and 
characterization of Ub linkages and, very generally, shape. One method which does 




to isolate, and/or confirm the presence of, specific protein substrates from samples. 
There are many anti-Ub antibodies, and some have linkage specificity. However 
immunoprecipitation does not always reveal the number of Ub moieties (unless 
coupled with intact mass analysis) or complete linkage other than the epitope. If there 
is a mixed linkage, for example, then the epitope of one of the linkages will match the 
antibody, but the other linkages in the polyUb maybe unaccounted for in the antibody 
based analysis alone.18 There is not yet an antibody for every linkage type either, so 
some linkages are impossible to identify by this method. It has also been shown that 
not all antibodies isolate the same cohort, which would introduce unexpected 
variables.19 There are antibodies which can isolate unanchored Ubs20 and some that 
isolate polyUbs,3 but more specific features (such as branching) cannot be elucidated. 
 Similar to antibody work, proteins called deubiquitinases (DUBs) have been 
used to reveal the structure of polyUbs without using mass spectrometry. DUBs 
remove ubiquitin isopeptide bonds either generally or at specific linkages. A process 
called UbiCRest (ubiquitin chain restriction)21 has been shown to effectively identify 
linkages present in heterotypic chains. Some topological determination has been 
accomplished using DUBs.22 These methods are extremely useful and have been 
implemented successfully in vitro experiments.23 However, the DUBs currently 
available do not cover all the possible Ub linkages, and the DUBs that have 
specificity have not been tested to confirm their specificity in all chain lengths and 
topologies.22 This is an uncertainty that fragmentation resulting from tandem mass 
spectrometry could overcome since the linkage present would produce unique 




 Many of the studies shown in Figure 1.3 have elucidated the linkages present 
and shown their importance in cellular functions using sequence mutations.24 By 
converting specific K residues to R, the general shape of the Ub can be maintained, 
but the conjugating abilities are completely lost. This means, for example, that if K63 
linkages are suspected to be involved in a process, researchers can genetically mutate 
the cells to produce K63R mutant Ubs and see if the functions being studied are 
perturbed.13,25 In this way, scientists have definitively defined functions without any 
uncertainty. However, these studies must disrupt the normal Ub pathway, which may 
have unpredicted consequences.26  
Two specific studies that attempted K to R mutations for topological 
determination came to the conclusion that they were unable to determine the exact 
topology of the polyUb chain using mutations. The authors suggest a chain shape and 
determined the linkages involved, but no more was definitively concluded.8,27 
Another K to R mutation experiment successfully demonstrated that K11 branched 
off K48 chains in vivo and that these chains allowed for a more efficient proteolysis.28 
However, all these processes involved multiple experiments where separate mutations 
were needed. These mutations not only involve more invasive biochemical techniques 
in vivo, but also require a lot of time in cell culture and genetic mutation experiments. 
To map the entire ubiquitinome would be a gargantuan biochemical undertaking 










Cellular systems have many different enzymes that cleave peptide bonds on 
proteins. These enzymes have been isolated and are now commercially available for 
general use. Trypsin is one of the most common cleavage enzymes; it cleaves 
specifically at arginine (R) and lysine (K) residues making it possible to predict the 
product peptides from large protein repositories. When these peptides are coupled 
with a LC-MS/MS analysis, the method is called bottom-up proteomics. The bottom-
up refers to the fact that the peptides must be pieced back together after identification 
by MS/MS and matched with a protein that has the same potential peptide products 
and sequence identified by MS/MS.29 
Many laboratories use trypsin cleavage to locate ubiquitination on proteins 
because it leaves a -GG tag on the ε-amine of the target protein’s lysine after trypsin 
cleaves at R74 of Ub. When peptides from the conjugated protein are sequenced by 
tandem mass spectrometry (MS/MS) and bioinformatics, the additional mass from the 
-GG tag, 114.043 Da, can be recognized and located.30,31,32,33 However, this technique 
shows neither the length nor the linkage pattern of the ubiquitination side chain, but 
can show all the linkages present (as Ub peptides with -GG tags) and the location of 







Figure 1.4. Visual representation of an ubiquitinated protein undergoing tryptic 
digestion. Cleavage at R74 of the Ub leaves a signature mass addition of 114.043 Da 
onto the modified lysine (K*) due to the -GG remnant. (Adapted from ref 31) 
 
 
Many ubiquitinomal features have been interrogated using bottom-up -GG 
tagging. This method allows for a facile shot-gun proteomic study to reveal Ub levels 
in the cell and to quickly identify the sites. This method allows for quantitative 
measurements which can compare the amount of ubiquitination compared to other 
PTMs.35,36 For example, through -GG tagging, it was found that total Ub is 486.4 
pmol/mg (or 0.42%) total protein of the cellular cargo in HEK293 cells.36 It was also 
determined that monoUb was the most abundant form of around 60%,37 but that the 
cellular levels of mono and polyUb change depending on the system. PolyUb reached 
at most 14% of the total Ub in the MEF cell line.37,36  
Bottom-up proteomics has also allowed for quantification of the linkages 
present in the cell. By using SILAC (Stable Isotope Labeling with Amino acids in 
Cell culture) with -GG tagged peptides the relative abundance of the linkages were 
found to be K11 (35%), K48 (30%), K63 (11%), K6 (11%), K27 (7%), K29 (4%), 




the complexity of the Ub pool cannot be reduced to a few highly abundant linkages. 
A method is needed that can correctly assign all linkages present. Bottom-up 
proteomics has been able to find all the Lys linkages, but it is limited in knowing their 
relationship to each other and the chain topology, which has been shown to have 





An alternative approach is to identify proteins directly from the cell without 
digesting to peptides, and is thus called top-down proteomics. Top-down proteomics 
can be very beneficial for the identification of a multitude of PTMs because the whole 
protein is kept together, and consequently, the potential to map co-PTMs (multiple 
PTMS on the same protein) becomes much more probable. For example, a bottom-up 
experiment could find a peptide with an acetylation and then a different peptide of the 
same protein with a phosphorylation site. How would a bottom-up user tell if the 
acetylation and the phosphorylation were happening together on the protein or if the 
protein had multiple proteoforms? It is also possible to lose modifications in bottom-
up because they are a smaller sub-set of a more common PTM on the same peptide. 
Common data dependent tandem mass spectrometric experiments may not collect 
data on these lower abundant peptides.39,40 With sensitive top-down proteomics, 
proteoforms and isoforms can be completely characterized. 
Top-down is limited, however, by the instrumentation’s fragmentation ability 




resolution to separate 13C isotopes, as seen in Figure 1.5 for deconvolution and charge 
state definition. Also the larger the peptides or proteins being subjected to 
fragmentation, the more inefficient the fragmentation tends to be. This is because, in 
collisionally induced dissociation, (CID and HCD) the energy can be dispersed across 
bonds and rotations and the larger the precursor molecule, the more dispersion 
possible.41 In electron capture/transfer dissociation (ECD/ETD), the reaction is 
generally more efficient for precursor ions with higher charge states, which, in 
electrospray ionization, means a larger intact mass.42,43 Very large proteins are still 
limited in ECD/ETD fragmentation when the electron transferred only results in 
charge state reduction. Supplemental collisional energy has been successful in 










Figure 1.5. Example spectrum of an intact Ubiquitin dimer linked at K63. The isotope 
cluster represented above is for the charge state 20. The inverse of the difference 
between two adjacent m/z isotope peaks (13CX+1-
13CX), shown between the arrows, is 
the equation used to determine the charge state (z). 
 
 
Each Ub adds ~8500 Da and the mass of a protein conjugated to a long 
polyUb will quickly exceed the current upper mass range of many top-down tandem 
mass spectrometers used in a chromatographic time-scale. Also each addition is of the 
same chemistry and thus makes polyUb of different lengths difficult to separate. The 
linkage location changes the shape of some Ub dimers,45,46 but may not affect their 
retention in the typical stationary phases used and so they may not separate easily. 
The LC-MS/MS instrumentation is available to detect larger masses, and is becoming 
more common in laboratories. This along with improved column chemistries coupled 






Instead of using one extreme (bottom-up) or the other (top-down), it is 
possible to use a chemical reaction that can give the benefits of both. A well-
documented chemical reaction that cleaves selectively at aspartate (D) is microwave 
accelerated acid cleavage (MWAC).46 D residues are less common than the cleavage 
sites of tryptic cleavage methods (K and R), so it leaves larger peptides and will not 
remove common PTMs on the proteins, leading to this method being called middle-
out.47,48,49,50 
Another common method for creating larger middle-out-sized peptides is to 
run minimal enzymatic cleavage. Trypsin can be limited in its digestion by mutations 
of the enzyme and/or lowering the reaction time, referred to here as minimal 
trypsinolysis.51 Acid hydrolysis can also be limited by the time the reaction is allowed 
to proceed.52 Both options will create peptides that retain more information on the 
proteins’ overall structure, due to missed-cleavage events leaving longer sequences 
(>2000 Da). Both these reactions can create a more telling polypeptide for polyUb 
chains in particular.51,49,52,53  
Trypsin cleaves Ub preferentially at the R74 leaving -GG tags on any 
modified lysine residue.54 If the time is limited, cleavage at R74 will be one of the 
few which occurs. This means that any isopeptides that are branched might be seen as 
multiple -GG tags on a single Ub peptide.51 (Figure 1.6) The convenience of this 
middle-out method is that the -GG tags can be searched as variable modifications 
using well established programs. Limitations of minimal trypsinolysis is that the C-




type, thus losing definition of the potential attachment sites of the polyUb chain in a 
mixture. Also, this creates a problem with more complex, unusual structures of 
polyUb, which have branched and unbranched sections (as in Figure 1.2e). In brief, if 
all the R74 are cleaved in the chain, there would be no way to tell on which Ub 




Figure 1.6. Visual representation of minimal tryptic digestion of ubiquitin chains that 








Time-limited MWAC on polyUb results in many peptides, which can be used 
for polyUb chain analysis. (Figure 1.7)49 The goal of using acid hydrolysis is to retain 
the C-terminus at all branch points. By doing this, a study of a complex polyUb 
mixture can prove the Ub chain is unanchored or could show the exact spot on the 
conjugated protein that the chain is anchored. This conjugation information is lost in 
trypsin analysis.7 Another benefit is that certain Ub-like (UbL) proteins (i.e. Nedd8) 
also produce -GG tags when digested with trypsin, but when using acid hydrolysis, 
even complete acid hydrolysis, there is no more overlap in the attached isopeptide 
sequence.55  
 The main limit of acid hydrolysis is that the reaction must be tailored to 
create incomplete cleavage, producing a large mixture of polypeptides which will 
lower the signal of the target peptide. A simple example of this is the loss and 
retention of the D on the termini of the peptides in acid cleavage. Some peptides will 
retain the D on the N-terminus, on the C-terminus, or none. This will split the signal 
of the peptide into four different possible masses, complicating not only the 
separation and detection of the digestion products, but the interpretation of the data 







Figure 1.7. Product spectrum of monoubiquitin hydrolyzed with acetic acid at 1400C 
for 60 sec in microwave assisted acid hydrolysis. Peptides are labeled with the amino 




Fragmentation of Large Peptides/Proteins 
The fragmentation experimentalists seek is a process in which a peptide 
backbone is broken in a predictable and reliable manner. A precursor MS is acquired 
and a peptide/protein m/z is selected from the available ions for fragmentation. Once 
fragmentation on the isolated m/z occurs, the fragment ions are scanned to produce a 
product ion spectrum. These fragments can be used as a ladder to piece together the 
amino acid sequence. The most common and useful fragmentation patterns are 












Collisionally Induced Dissociation 
 
The most common technique for inducing fragmentation of peptides/proteins 
is collisionally induced dissociation (CID). In CID, the precursor ion is moved into 
the collision cell where it is activated by multiple low-energy collisions with an inert 
gas (Ne or Ar). The dominant fragmentation pattern seen after CID is a series of b  
and y ions. (Figure 1.8 in blue)43 The activation energy of this technique is limited by 
the mass of both collision partners; the larger the precursor ion, the less effective the 
fragmentation will be.55  
Another collisional activation technique is higher-energy collisional 
dissociation (HCD).57 As its name suggests, HCD is a higher energy fragmentation 
technique, comparable to CID. The main difference lies in the fact that the energy of 
the collision can be as much as 100 times larger in HCD compared to CID.57 This is 




higher potentials. The type of high energy collision discussed in this dissertation is 
specific to ThermoFisher Scientific instruments. 
 
 
Electron Transfer Dissociation 
 
Electron transfer dissociation (ETD) is a fragmentation technique that requires 
a reagent anion to transfer an electron to a precursor cation to induce 
fragmentation.40,58 ETD was conceptualized as a way to allow electron capture 
dissociation (ECD) to occur in mass analyzers other than an FTICR.59,58 Briefly, ECD 
involves the capture of an electron released from a heated filament source to react 
with multiply changed cation peptides. Both reactions result in a non-ergodic 
pathway, which means that fragmentation does not involve intramolecular vibrational 
energy redistribution.59,58 ETD generally produces c and z ions (Figure 1.8 in red), as 
that is the bond where the radical reaction centers, and ETD has been reported as 
more effective at fragmenting higher mass peptides then CID or HCD.43,60 The higher 
the charge on the peptide/protein, the faster the electron transfers and the reaction 
occurs, and thus a lower reaction time is required for ions with larger charge states. 
Because the reaction is non-ergodic, the side-chains and PTMs on proteins or 
peptides will remain intact while the N–Cα bond preferentially breaks.40,41 
Sometimes fragmentation does not occur as readily and the major ion present 
in the product spectrum will be the charge reduced ion radical form of the precursor 
ion. Thus the base peak becomes the charge reduced precursor ion and the fragment 




ETD with HCD or CID to induce fragmentation.43,61,62,63 By doing so, the ETD non-








The first generation of the orbitrap instrumentation introduced by ThermoFisher 
Scientific was the orbitrap LTQ-XL. (Figure 1.9) This instrument uses the resolving 
power of a standard orbitrap (maximum of 100,000 at 200 m/z)65 to enable the study 
of large peptides and small proteins. The precursor ions enter the orbitrap by first 
being collected and correctly oriented in the C-trap. (Figure 1.9) The mass/charge 
ratio is measured on an orbitrap by dividing a constant (k) (found for each orbitrap 
specifically) by the frequency of the ions’ movement along the length of the orbitrap 
(z-axis) (ω). (Eq. 1.1) 
        Eq. 1.1  
 Once a precursor ion is selected for fragmentation, that ion is moved into the 
linear ion trap (for CID and ETD) or a multipole (for HCD) where the respective 
fragmentation occurs. (Figure 1.9) From there the mass analysis on the product ions 
could be accomplished via the orbitrap (high resolution) or the linear ion trap (low 




studies.66,67 The orbitrap LTQ-XL was, however, limited in its ability to fragment 
large proteins.68 The orbitrap LTQ-XL was optimized to run collisionally induced 
dissociation (CID) as the main fragmentation technique. However, CID is known to 
be less efficient at fragmentation of larger masses.43  
 
 




Orbitrap Fusion Lumos Tribrid 
 
The latest innovation from ThermoFisher Scientific is the orbitrap Fusion 
Lumos Tribrid mass spectrometer. As with all orbitrap mass analyzers, the resolution 
is incredibly high. However, the Fusion Lumos contains an ultra-high field orbitrap 
(unlike the orbitrap LTQ which had a standard orbitrap) acquiring a resolving power 





Figure 1.10. Layout of the orbitrap Fusion Lumos Tribrid (http://planetorbitrap.com) 
 
 
The orbitrap Fusion has other improvements than just the orbitrap mass 
analyzer compared to the first generation. One of the most notable for top-down and 
middle-out analyses is more efficient pumps; these provide lower pressure in the IRM 
(ion routing multipole), orbitrap, and C-trap, which allows for larger masses to 
transfer more efficiently into the orbitrap for analysis. It also has a wider transfer 
tube, which allows for higher sensitivity, especially of high mass molecules. Another 
improvement that allows for more efficient top-down experiments is the use of a 
segmented linear ion trap (LTQ) (which was first introduced in the orbitrap Velos). 
The segmentation allows for more ions to enter the ETD reaction cell while keeping 
the reactive anion separate before they mix and the reaction takes place. As seen in 
Figure 1.10, there is a separation of the high pressure and low pressure LTQ, allowing 




compared to that of the XL. To further improve ETD capabilities (which are 
necessary for our top-down experiments), the ETD source was moved from the back 
(Figure 1.9) to the front of the instrument (Figure 1.10). In the creation of the 
fluoranthene anion, there is also cation and neutral products produced. By running the 
fluoranthene product though the active beam guide, the anion can be separated and 




Bottom-up bioinformatics searches that match fragmentation data with large protein 
repositories is a well-established medium.69 These programs are able to search for     
–GG tagged ubiquitination sites on peptides, on a chromatographic time-scale.33,34 As 
discussed previously, using bioinformatics in bottom-up proteomics has resulted in 
most of the qualitative and quantitative information available now for the 
ubiquitinome. 
Middle-out spectra resulting from missed-cleavage are more difficult for 
search engines’ algorithms to decipher. The processing power required to search and 
match the complex peptide mixtures from time-limited middle-out cleavage is 
available in new software such as Proteome Discoverer (PD) and ProSightPC 
(ThermoFisher).70,71,72 However, the software still necessitates confirmation of the 
isopeptide linkage by manual curation.51,52 
 A few programs are available to process top-down proteomic data.70,73,74 The 




differences and allow the user to define the PTM (with suggestions from the program) 
by manual curation.70,75,74 The former would be required for Ub identification. 
One important limit of top-down proteomic algorithms is that limited 
fragmentation to completely characterize a PTM will dispute any identification’s 
statistical significance and render the identification unusable;76 this is especially true 
in analytes with isopeptide bonds. There is currently software that can accommodate 
for disulfide bonds,77 however there is not an algorithm for dissecting intact polyUb 
isopeptide bonds. The difficulty lies in the fact that, for polyUb, there are isomeric 
subunits, which will give off almost entirely the same fragment ions. This leaves only 
a small set of ions that can be used to differentiate the identical theoretical structures. 
By using a graphical viewer to show the fragmentation present, the isopeptide 
linkages can be identified and bolstered by computer supported manual interpretation. 
 
Objectives 
Ubiquitination is a common post translational modification (PTM) which is 
traditionally discovered as a -GG tag on a lysine residue of a peptide after 
trypsinolysis. The small mass tag, a product of cleavage at R74 on Ub leaving 
glycinylglycine (-GG) isopeptide linked to a lysine, is used as a variable modification 
in proteomic search engines. These identifications can define the location of mono or 
polyUbs on target proteins, but tells nothing about the Ub chain itself. 
Characterization of the Ub chain topology is an ill-defined branch of proteomics, but 
is important for determination of the function of the ubiquitinome. It has been shown 




different functionalities within the cell. Not only that but very specific linkages with 
difficult to decipher topologies have been shown to have important functions. The 
methods are normally very tedious, as they require protein mutations within a cell 
line, or the use of many different antibodies or DUBs. It is difficult to determine both 
the linkages and the chain topology present in one experiment. To date there has not 
been a study that could map structures of the polyUbs in a facile manner. The work 
outlined in this dissertation will show that, by the use of mass spectrometry, the chain 










Chapter 2: Mass Spectrometric Analysis of Ub Dimers (Adapted 





Ubiquitin (Ub) dimers are the most simple and robust form of polyUb.78 
Despite their simplicity, Ub dimers are reported as kinase activity activators when 
anchored on NEMO (NF-κB essential modulator),79 they control specific hydrolysis 
and enzymatic activities,80 and they have been found to have multiple specific DUBs. 
This suggests dimers have multiple relevant biological activities. Dimers have also 
been reported as unanchored in vivo (Figure 2.1).81 Currently, functionality is not 
known for unanchored dimers; they have been suggested to be “building blocks” for 
the formation of larger chains.81,82 The Ub that has a free C-terminus (unanchored 
seen with the -GG tail) or is attached to a substrate protein (anchored) is called the 
proximal Ub, labeled with a P. The Ub that has no other Ub attached to it, except by 
its own C-terminus, is called the distal Ub labeled with a D (Figure 2.1). For anchored 
chains, an S (for substrate) can simply be added within the subscript to represent the 













NMR and crystallography studies show that the different linkages within 
ubiquitin dimers create different overall quaternary structures. These differing 
structures have been assigned as the reason for the linkage based functionality.83 For 
example, the two most abundant Ub isopeptide linkages, K48 and K63, form two 
distinct inter-subunit topologies.84 K48 linked dimers form a closed conformation 
where the interactions keeping the two Ub moieties within close proximity is a 
hydrophobic patch including residues L8, I44, and V70.85 This is in contrast to the 
topology of K63 dimers, which have an open conformation with little to no 








As stated in the first chapter, one of the most difficult aspects of ubiquitin 
chains’ structural determination by mass spectrometry comes from the fact that the 
amino acid sequence is repeated in all the moieties within the chain. This creates 
many fragments that are redundant for each moiety and are thus not useful for 
determination of the chain’s linkage (Figure 2.2). Complexity of the chain increases 
as the chain length increases (due to more possible topological features and possible 
linkage combinations), making analysis more difficult. Thus by starting with dimers, 
we can explore what aspects of the simplest example are unique, which will help 
build the method to longer and more complex structures. 
As seen in Figure 2.2, the distal and proximal ubiquitin have the exact same 
sequence. The resulting redundant ions are largely ignored for any structural analysis. 
The ions that are unique and informative are starred in Figure 2.2. Specifically for 
unanchored chains, the C-terminus of the proximal Ub will be free. The series of z 
ions (seen in Figure 2.2 starred in gold), from the free C-terminus are unique and can 
tell the location of the linkage on the proximal Ub.  
The same principle can be applied to the anchored dimer, except uniqueness is 
found in the z or y ion fragments on the proximal after the mass addition of the 







Figure 2.2. Theoretical full fragmentation pattern of c and z ions resulting from ETD 
fragmentation of Ub–48Ub. The gold stars represent unique z ions and the blue stars 





To eliminate some of the redundancies that result from two identical moieties, it is 
possible to truncate the Ub dimer to a product that will give more unique fragment 
ions. This will also lower the intact mass, making it easier to detect and fragment on 
less efficient mass spectrometers, which give poor fragmentation data for the large 
intact masses of dimers.81 More unique fragments will make linkage site 
identification simpler. (Figure 2.3) However, by truncating even just the distal Ub, 
information on the length of the polyUb chain is lost. There is also a plethora of 
different peptides created when using time-limited reactions. Thus a more complex 
mixture of ions must be separated using pre-MS/MS HPLC. Furthermore, the mixture 




fragments of Ub, making separation more difficult. If the length is known (perhaps by 
using middle-out as supplemental to a top-down analysis), then a MWAC middle-out 





Figure 2.3. Theoretical full fragmentation pattern of b and y ions resulting from CID 
fragmentation of a K6-linked diUb. In this example of a truncated, branched peptide, 
all fragments present are unique. Truncation is achieved by time-limited MWAC. 
  
 
 The goal of the experiments reported in this chapter is to completely 
characterize the linkages present in a set of seven different isopeptide-linked Ub 
dimers. This will be done using the most current instrumentation available for top-
down proteomics. This chapter will also discuss a method compatible with the use of 
older instrumentation that is not able to produce viable top-down results. The 
overarching goal is to set up a protocol that, along with characterizing Ub dimers, can 






Methods and Materials 
 
Synthesis of Ubiquitin Dimers. Ubiquitin polymers were prepared either 
chemically (K6, K11, K27, K29, K33 and Rub1-Ub and Ub-Rub1)87 or enzymatically 
(K48, K63)88 by members of the Fushman Laboratory. 
Middle-Out Microwave-Assisted Acid Cleavage. Diubiquitin samples were 
diluted to 0.1mg/ml in a 100 µL 12.5% acetic acid solution and digested at 1400C 
using 300W microwave energy varying times in a CEM Discover microwave 
(Matthews, NC). Acidic solvent was removed by lyophilization in a FreeZone 2.5 
Plus from Labconco Corporation (Kansas City, MO) before further analysis. These 
conditions have been previously reported to hydrolyze proteins with high selectivity 
at Asp residues,50 yielding peptides that produce searchable CID spectra.72  
 Middle-Out MALDI Analysis. A Kratos Axima CFR MALDI-TOF MS 
(Shimadzu Biosciences, Columbia, MD) was used in linear mode to acquire mass 
spectra. One hundred scans were integrated per spectrum. Laser voltage was 84V and 
the matrix used was α-cyano-4-hydroxycinnamic acid at 10mg/ml in 70/30/0.1 
acetonitrile/water/TFA. The 0.1mg/ml protein sample and the matrix solution were 
mixed 1:1 by volume for MALDI analysis.  
 LC-MS/MS of Middle-Out Peptides. After lyophilization, samples were 
diluted with HPLC grade water with 0.1% formic acid back to 100 µL. 5 µL of this 
solution was then injected, concentrated and desalted on a C8 trapping column (0.5×3 
mm, Agilent Technologies) for 5 minutes before being separated through a pepSil C8 
column (Column Technology Inc., Fremont, CA) with a flow rate of 300 nL/min and 




and 0.1% formic acid; Solvent B: 97.5% ACN, 2.5% HPLC grade water and 0.1% 
formic). Analysis was performed in reverse-phase using a 2D nanoHPLC system 
(Shimadzu BioSciences, Columbia, MD) interfaced to an LTQ-orbitrap XL mass 
spectrometer (Thermo-Fisher, San Jose, CA). Precursor masses were acquired with a 
resolution of 60000 while fragment ions were acquired with a resolution of 30000 all 
within the orbitrap mass analyzer. Fragmentation was accomplished by CID with 
collision energy normalized at 35% NCE. The four most intense multiply charged 
precursor ions calculated from the intact peptide mass were targeted and fragmented 
in each cycle.  
Intact protein analysis by LC-MS/MS. Intact dimers were diluted in Solvent 
A (97.5% water, 2.5% ACN and 0.1% formic acid) to 0.03 mg/mL The 
chromatography was performed using an Ultimate 3000 ultra-high performance liquid 
chromatograph (ThermoFisher Scientific, San Jose, CA) interfaced to an orbitrap 
Fusion Lumos Tribrid mass spectrometer (ThermoFisher Scientific). Two µL of intact 
sample were injected, concentrated, and desalted on a PepSwift Monolith trap (200 
µm x 5 mm) for 5 mins before separation on a ProSwift RP-4H column (100 µm x 25 
cm) (ThermoFisher Scientific) with a linear gradient of 30% to 60% solvent B (75% 
ACN, 25% water, 0.1% formic acid) over 15 mins. The potential for in-source 
fragmentation was set to 30V. Precursor and fragment ion masses were acquired with 
a resolution of 120,000 at 200 m/z. Fragmentation was triggered in data-dependent 
mode by electron transfer supported by chemical ionization (ETciD) with a 6 msec 




Interpreting the Spectra.  Precursor and fragmentation ions were 
deconvoluted using Xtract 3.0 (ThermoFisher Scientific). Fragment ions from the 
most intense m/z precursor ions selected in data-dependent mode were combined and 
then matched against the sequence of monoubiquitin.  ProSightLite 
(http://prosightlite.northwestern.edu/) graphical interface75 was used with a 5 ppm 
mass tolerance for top-down results and 20 ppm mass tolerance for middle-out 
results. The strategy utilized the monoubiquitin sequence as a template to assess the 
fragmentation patterns of each of the Ub moieties present in the dimers. ProSight Lite 
allows for custom mass additions to any amino acid in the template sequence. 
ProSightLite also identifies ions as c and z, formed by ETD, in red, and b and y, 
formed by CID, in blue. 
 
 




Unanchored natural diUb with all seven isopeptide linkages were obtained and 
analyzed to determine if mass spectrometry could be used to determine the linkages 
present. To interpret the fragmentation spectrum and determine the linkage site, the 
number of Ub moieties first must be determined, as a different method must be 
applied to each polyUb chain length (discussed in subsequent chapters). Ub dimers 
were initially identified by their intact mass. All intact Ub molecular masses were 




Table 2.1. Intact mass analysis of each isopeptide-linked diUb. Theoretical mass of 







Ub–63Ub 17101.30 0.6 
Ub–48Ub 17101.24 0.6 
Ub–33Ub 17101.26 3.5 
Ub–29Ub 17101.24 1.2 
Ub–27Ub 17101.28 2.3 
Ub–11Ub 17101.21 1.2 












Once the polyUb is determined to be a dimer by its mass (Step 1: Table 2.1), a 
specifically designed workflow can be followed to determine all aspects of the 
chain’s structure (Figure 2.4). Step 2, interrogate the proximal Ub occurs next. In 
Step 2, the fragmentation pattern of Ub is confirmed (to avoid the rare case that the 
intact mass is the same as that of another protein). For unanchored dimers, the y or z 
ions from the proximal Ub will be unique to a certain linkage. Practically, this means 
that wherever the y or z ions from the unmodified sequence of Ub drop off is where 
the linkage should be located in the proximal moiety of the dimer. Since there is only 
one Ub moiety in the dimers that has a Lys-linked isopeptide, this should be the only 
topological feature that needs addressing. In future chapters, there will be many more 
complex steps needed to determine topology. Step 3, linkage determination, aims to 
confirm the linkage that is suggested in Step 2. By adding the mass of the distal Ub to 
the N-terminus, fragmentation will appear that specifically represents only the 
linkage. By using all the information built by the previous steps, Step 4 is the 
visualization of the final structure using the fragmentation available.  
 The theoretical idea of Step 2 is visualized here in Figure 2.5. All the 
isopeptide-linked dimers can be seen to have nearly complete fragmentation coverage 
of the Ub sequence with the b and c ions, suggesting monoUb is the correct sequence. 
The y and z ions tell a different story. The C-terminal fragment ions (y and z) 
consistently stop before the theoretical mass addition of the distal Ub on the proximal 
Ub. For example, in Figure 2.5g (Ub–6Ub), y and z ions can be followed all the way 
past K11 (eliminating that Lys as having a mass addition) and up to L8, stopping 








Figure 2.5. Visualization of Step 2, interrogate proximal Ub, in the unanchored Ub 





 Step 3 can then be implemented to confirm the finding in Step 2. What this 
means practically is that, if the mass addition of the distal Ub is placed on the M1 (the 
N-terminal) of the proximal Ub, the only fragment ions that appear should be in 
support of the Lys that is suggested as the linkage site in Step 2 (Figure 2.6). For 
example, for the K48 dimer, the y and z ions stop before K48, suggesting it as the 
correct isopeptide linkage location (Figure 2.5b), however, this prediction is based 
only on the absence of one type of ion (y or z). To confirm the linkage at K48 the 
fragmentation pattern was assessed when the distal mass is added to the M1. Figure 
2.6b shows that all the redundant fragment ions disappear and what is left are the 




supporting other Lys residues can be seen, and the c ions formed start after K48 (at 
E51). Therefore all the unique ions support only K48. This is true for all the linkages 






Figure 2.6. Step 3, linkage determination, visualized for all seven isopeptide linkages 
of diUbs. The initial methionine is highlighted to indicate the trial addition of the 
mass of the distal Ub (8541.6056 Da), which is represented by a blue ball. 




Once the linkage location is confirmed, Step 4, Final structure and 
fragmentation can be visualized by placing the distal Ub on the predicted Lys and 








Figure 2.7. Visualization of Step 4, final structure and fragmentation. Each Ub dimer 









To perform top-down protein analysis requires instrumentation that has high 
enough sensitivity and fragmentation capability to fragment large intact masses of 
proteins. If this is not available, or if a top-down experiment did not provide enough 
fragmentation for a confident identification of a polyUb chain, that work can be 
supplemented with a middle-out workflow. In the case of Ub dimers, MWAC 
reproducibly produced peptides that retained the C-terminus of the proximal Ub and 
truncated the proximal and distal Ubs to produce a peptide that was lower in mass and 




Figure 2.8. Truncation of an intact Ub dimer linked at K48 to a middle-out peptide. 
Mass of the intact dimer, 17101.22 Da, is reduced to 6942.77 Da after limited 







MWAC is limited to produce missed cleavage events by lowering the time of 
the reaction. The complete digestion of diUb takes 15 mins, but nearly complete 
digestion can also be seen in as little as 3 mins. Different short time trails were 
attempted to see which produced different truncated peptides (Figure 2.9). A 30 sec 
digestion produced many differently massed peptides according the MALDI-TOF 
analysis, and, relative to the 20 and 10 sec runs, there was very little intact Ub left 




Figure 2.9. Time-trials for MWAC of a K63 linked Ub dimer. The control in 
red is the spectrum of the matrix, α-CHCA, and the rest are spectra of products from 
increasing times of MWAC. At time 0 sec we can see the MH+ at approximately 
17100 Da, the MH+2 at approximately 8550 Da, the MH+3 at approximately 5700 Da, 






 Precursor mass analysis on the orbitrap LTQ-XL revealed high mass 
accuracy (all errors fell within 11 ppm) for each of the truncated middle-out peptides 
of interest. (Table 2.2) An interesting note on the MWAC products is that the 
truncated peptides selected here are not all unique to only one linkage with the 
exception of the K63 linkage product. For example, the truncated peptide selected for 
K48 in Table 2.2 can also be seen in the hydrolysis of K63 linked dimer, but the 
hydrolysis product for K63 would not be seen in a hydrolysis of K48. (Figure 2.10) 
This means that the intact mass of the peptide cannot definitively identify the linkage 
as K48 (or K33, K29, K27, K11, K6), but must be coupled to fragmentation data in 
tandem mass spectrometry to identify the linkage. The only acceptation to this rule is 
K63 linkage, whose mass is unique to the linkage.49   
 
 
Table 2.2. Sequences and the theoretical and observed monoisotopic masses of the 












Figure 2.10. The extracted ion chromatograms (XIC) for A. hydrolysis products of 
K63 linked dimer and B. hydrolysis products of K48 linked dimer. Sequences of the 
truncated peptides of interest represent the masses selected for the XIC. 
 
 
To properly characterize the linkages, CID fragmentation was used on 
targeted m/z values. The resulting fragmentation patterns are seen in Figure 2.11. 




case of K27, K29, and K11, linkages were constricted to only two possible linkage 
sites. The K27 and K29 residues are so close that it was difficult to obtain 
fragmentation to distinguish them on the first generation orbitrap. They could be 
differentiated in complete acid hydrolysis seen in Appendix Table 1 and Figure 1. A 
lack of fragmentation density was not an issue with the reported top-down work, as 






Figure 2.11. Fragmentation patterns for selected time-limited MWAC products for all 
isopeptide-linked Ub dimers. Lysine residues highlighted in gold with a black box 
surround are the sites of the isopeptide linkages. The gold highlighted Q in b. 






Ub dimers can be completely characterized on a chromatographic time scale 
by LC-MS/MS using a top-town proteomic workflow. To accomplish this, it is 
necessary to take advantage of recent advances in highly efficient fragmentation and 
mass analyzers that are capable of high mass detection. A facile workflow directed 
specifically at characterizing the linkages of Ub dimers was created, which takes 
advantage of these advances. However, if this equipment is unavailable, 
characterization can be accomplished by middle-out analysis. 




Chapter 3: Mass Spectrometric Analysis of Ub Trimers 





Ubiquitin (Ub) trimers have been reported in vivo at low relative abundance 
and are not a common length for polyUb studies.33 Trimers were reported as active, 
potent, and specific activators of RIG-I,1881 and K48 linked trimers were reported to 
have greater proteolytic ability than dimers, but less than tetramers.86 More specific 
functions have not been elucidated. 
 Trimers may not be as prevalent or active in cells compared to dimers and 
tetramers, but developing a method to characterize trimer is vital to conceptualize a 
facile strategy to characterize longer chains that are readily found in cells. Compared 
to dimers, trimers have an extra ubiquitin moiety, and so must be considered 
differently because distinctive topologies, along with all 8 linkages locations, are 
possible.53 The triUb chain can form theoretically two different topologies: 
unbranched and branched. (Figure 3.1) The unbranched chain in Figure 3.1 has one 
proximal and one distal Ub, like the dimers along with a new and unique moiety 
called the endo Ub. (Figure 3.1 left) The endo Ub in trimers is defined as a Ub moiety 
with a single Ub on its C-terminus and another Ub on one of its Lys residues. The 





Figure 3.1. The two general topologies available for trimers are unbranched (left) and 
branched (right). The unbranched chain has three distinct moieties, a proximal, distal 
and endo, whereas the branched has no endo, only a proximal and two distals. 
 
 
 In an unknown trimer, there would be 92 possible combinations of the 
different topologies and linkages (64 linkage possibilities for unbranched and 28 for 
branched).33 When all the moieties result in almost the same fragmentation, the 
question becomes, what fragmentation can we use to determine the topology and the 
linkage? It would be impossible to tell the difference between a branched Ub and an 
unbranched Ub by almost all the fragment ions that appear. The difference between 








  To differentiate the two available topologies, fragmentation must find which 
is truly unique to only one topology. This fragmentation is seen in the endo Ub of the 
unbranched Ub–6Ub–63Ub between K63 and the C-terminus (G76) shown in Figure 
3.2 in green. The masses of the fragmentation within this region is diagnostic for the 
endo Ub because only the proximal Ub is attached to the C-terminus in an 
unbranched Ub, but in a branched, there would be no moiety that has only one Ub 
attached to the C-terminus of another moiety. Both distals in the branched Ub have a 
proximal and the other distal mass linked to the C-terminus; thus two moieties are 
added (Figure 3.2). This is also true for fragmentation toward the N-terminus, where 
the endo Ub containing moiety would have fragment masses in the same region with 
only one Ub added to the N-terminal.  
Shown in Figure 3.2 the fragment ions marked with purple and gold stars are 
unique to the linkages present, but not the topology (branched vs. unbranched). The 
gold starred fragments are unique to the linkage on the proximal Ub and would be the 
same for the branched and unbranched chains. This is the same principle as Step 2 in 
Figure 2.4. The purple starred fragments show the fragment ions that are unique for 
the linkage in the proximal for the branched, and in the endo Ub for the unbranched. 
(Figure 3.2) This chapter’s aim is to prove this theoretical concept and show a mass 







Figure 3.2. Theoretical full fragmentation pattern for two Ub trimers that differ only 
in topology. Color coding shows the fragmentation that is unique to the linkages 
present, but the same in both (purple and gold) and fragmentation that is different 
between the topologies (green). The top image is that of a unbranched Ub–6Ub–63Ub 







If top-down methods are unable to differentiate the topologies, or if there isn’t 
enough fragmentation to determine the linkages present, middle-out methods may 
prove useful. If hydrolysis occurs on only the distal Ub moieties at D52 (colored red 
in Figure 3.3), then the chain can be truncated to produce a smaller more easily 
fragmented peptide (each truncation at D52 in the distal Ub results in a reduction of 
5816.2 Da). The unbranched chain will be reduced from 25624.8 Da to 19808.6 Da. 
(Figure 3.3, Ub–6Ub–63Ub) Better fragmentation may make it easier to identify the 
endo Ub, proving the topology. On the branched chains both distal Ubs can be 
truncated reducing the mass from 25642.8 Da to 13974.6 Da. (Figure 3.3 [Ub]2–
6,63Ub) By doing so the sequence on the proximal Ub is distinctive and there are 












Figure 3.3. Ideal truncation of a. the unbranched (Ub–6Ub–63Ub) and b. branched 
([Ub]2–











Methods and Materials 
 
Synthesis of Ubiquitin Trimers. Ub–33Ub–33Ub and [Ub]2–
11,33Ub were 
assembled chemically through silver-mediated ligation of an activated Ub to the 
selectively deprotected lysine of the other Ub.88,89 [Ub]2–
6,48Ub (E1, Ubch7, and 
NleL), [Ub]2–
11,63Ub (E1, Ube2s, MMS2, and Ubc13),46 Ub–48Ub–48Ub (E1 and E2-
25K),85 and Ub–63Ub–48Ub (E1, MMS2, and Ubc13, E2-25K)23 were generated 
enzymatically.85,45 All chains were produced by members of the Fushman Laboratory. 
Trimer Analysis by LC-MS/MS with ESI. Intact trimers were diluted in 
solvent A (97.5% water, 2.5% ACN and 0.1% formic acid) to 0.03 mg/mL The 
chromatography was performed using an Ultimate 3000 ultra-high performance liquid 
chromatograph (ThermoFisher Scientific, San Jose, CA) interfaced to an orbitrap 
Fusion Lumos Tribrid mass spectrometer (ThermoFisher Scientific). Three µL of 
intact sample were injected, concentrated, and desalted on a PepSwift Monolith trap 
(200 µm x 5 mm) for 5 mins before separation on a ProSwift RP-4H column (100 µm 
x 25 cm) (ThermoFisher Scientific) with a gradient of 20% to 40% solvent B (75% 
ACN, 25% water, 0.1% formic acid) over 15 mins. The potential for in-source 
fragmentation was set to 10V. Precursor and fragment ion masses were acquired with 
a resolution of 120,000. Fragmentation was triggered in data dependent mode by 
electron transfer supported by chemical ionization (EThcD) with a 6 msec ETD 
reaction time and supplemental activation at 10% normalized HCD (optimized as 




down parameters provided by ThermoFisher Scientific were used with minimal 
altercations. 
Interpreting the Spectra.  Precursor and fragmentation ions were 
deconvoluted using Xtract 3.0 (ThermoFisher Scientific). Fragment ions from the top 
m/z precursor ions selected in data dependent mode were combined and then matched 
against the sequence of monoubiquitin using ProSight Lite 
(http://prosightlite.northwestern.edu/) with a 10 ppm mass tolerance. In our strategy, 
the monoubiquitin sequence is used as a template to assess the fragmentation patterns 
of each of the Ub moieties present in the trimer. ProSight Lite allows for custom mass 
additions to any amino acid in the template sequence. Masses equivalent to one or 
two Ub moieties were added, and changes in fragmentation patterns assigned by 
ProSight Lite were used to assign the topology of each trimer as branched or 
unbranched chain. This is discussed in detail in the Results and Discussion section. 
Finally, linkage sites were assigned by inspection of fragmentation patterns assigned 
to the monoubiquitin template. ProSight Lite also identifies ions as c and z formed 
primarily by ETD, and b and y formed primarily by HCD. 
Microwave-Assisted Acid Cleavage. Ubiquitin trimers were diluted to 0.15 
mg/mL in 12.5% acetic acid and digested for 60 sec at 1400C using 300 W of power 
in a CEM Discover microwave (Matthews, NC). These conditions have been 
previously determined to produce partial cleavage of polyubiquitins at Asp residues 
(Appendix Table 3).49,52 Digested trimers were lyophilized and resuspended in 
solvent A (97.5% water, 2.5% ACN and 0.1% formic acid) at 0.1 mg/mL for 




each digested sample were injected, concentrated, and desalted on a Zorbax C8 trap 
(0.5X3 mm, Agilent Technologies) for 5 mins before being separated on a Zorbax C8 
column (3.5 µm, 150 mm X 75 µm, Agilent Technologies, Santa Clara, CA) with a 
500 nL/min flow rate and a gradient of 30% to 37% solvent B (solvent B: 75% ACN, 








PolyUb chains were interrogated to find the topology and linkages present 
using one mass spectrometry based workflow. To determine and test a workflow, a 
set of six triUbs (Figure 3.4) were obtained. An orbitrap Fusion Lumos mass 
spectrometer is shown to provide and record extensive fragmentation in high mass 
proteins.90 However, in highly repetitive isopeptide Ub moieties, it is also necessary 
to be able to interpret the spectrum. Using a graphical interface to visualize the 





Figure 3.4. Sequence and connectivity of each unbranched (top 3) and branched 
(bottom 3) standard trimer. From top to bottom trimers present are Ub—48Ub—48Ub, 
Ub—33Ub—33Ub, Ub—63Ub—48Ub, [Ub]2—
6,48Ub, [Ub]2—
11,33Ub, and          
[Ub]2—
11,63Ub. Residues in red represent the modified lysines. Residues in blue 
represent mutations made for the synthesis of the trimer from K to R. Ub—63Ub—
48Ub also is missing residues G75 and G76 which could not be highlighted. Ubiquitin 






 The workflow designed for Ub trimers has many similar steps to that of the 
dimers. However there is a very vital step added to determine the topology of the 




Figure 3.5. Workflow designed specifically to characterize Ub trimers with each step 
described to the left. 
 
 
 The path for this workflow is specific to trimers, (Figure 3.5) and thus Step 1, 
“Molecular Mass” determination, must confirm the chain as a trimer. The 




further interrogated using ProSight Lite, which allows for custom mass additions to 
any amino acid in the sequence. In the “Proximal” step (Step 2) we follow the z ions 
from the free C-terminus of the proximal Ub. Where the fragmentation terminates is 
where one of (or the only) mass addition on the proximal Ub occurs. To determine if 
there are two Ub masses (unbranched chains) or one Ub mass (branched chains) 
added to that particular lysine, we move on to the “Establish Topology” step (Step 3). 
Does the addition of a single Ub mass to the C-terminus and another to the N-
terminus create diagnostic c or z fragmentation between E63 and G76? If yes, then 
the chain topology is unbranched, if no, then it is branched; as demonstrated in Figure 
3.2. Once the topology is known the “Linkage Sites” can be determined in Step 4 by 
adding the Ub moieties to a specific Lys residue, the fragmentation pattern that 
emerges will determine the linkages present. Once the linkage is known Step 5, the 
“Final Structure and Fragmentation”, can be visualized and put together and the 
chain, completely characterized. 
 
 
Table 3.1. Calculated and measured molecular masses of six triUbs. 








































High-resolution mass spectrometry was used to identify each isomer’s intact 
mass within 5 ppm. (Table 3.1) Once the sample is recognized as a Ub trimer by Step 
1, extensive fragmentation is required to determine all other features of the chain. In 
Step 2 all the fragment ions are matched using ProSight Lite to the sequence of the 
proximal Ub (Figure 3.6). High fragmentation density will support the tentative 
assignment as an Ub. In Step 2, a linkage site on the proximal Ub is elucidated. 
Because the only free C-terminus is in the proximal Ub, any z ions characterized on 
the monoubiquitin template must be formed from the proximal Ub. This series of z 
fragment ions will be terminated on the template when a mass addition occurs in the 
sequence (Figure 3.6). This is exactly the same concept as Step 2 from the dimer 
workflow (Figure 2.4). The only difference is whether we are adding two Ub masses 
(for an unbranched chain), or a single Ub mass (for a branched). 
When using ETD fragmentation with supplemental activation (by HCD in this 
chapter), fragmentation is not expected to occur readily from the supplemental 
activation.61,43 Because HCD is known to produce internal fragmentation,64 the 
present work uses high mass accuracy in the fragment ions and only plots the c and z 
ions from ETD. The non-ergodic fragment products of ETD will give more accurate 








Figure 3.6. Initial matches (Step 2) against the monoubiquitin template of fragment 
ions from six tri-Ub chains. Both c/z ions (red) are plotted. The predicted isopeptide 
location is boxed in black. 
 
 
Almost no information can be gathered about the linkage or topology using c 
ions, because all three N-termini of a native triUb chain can produce the same c ions. 
In this study unmutated distal Ubs will produce a redundant and indistinguishable set 
of c ions (Figure 3.6b and e) whereas the synthetic chains with mutations on the distal 
Ubs have c ions end at the first mutation. (Figure 3.6a, c, d, and f) All sequence 
variants are highlighted in Figure 3.4. However, even with mutations, the c ions that 
are present do serve to confirm the sample as a Ub. 
 Once the sequence is matched to Ub the question becomes: what is the 
topology of the chain? (Step 3) To answer this question the structural difference 
between the branched and the unbranched trimers must be understood. An important 
difference is shown in Figure 3.1 and 3.2. The unbranched trimer contains an “endo” 




residues, which the branched isomer does not. Diagnostic fragment ions (Figure 3.2 
green) can prove the presence of an endo Ub, thus an unbranched topology, and by 
their absence a branched topology (Step 3, Figure 3.7). In this step a new template is 
established using ProSight Lite in which the mass of a proximal moiety is added at 
G76. ProSight Lite is then used to map fragment ions against the modified template. 
Ions that are unique to an endo Ub are formed by c and z fragments between K63 and 
the C-terminus that carry the mass of the distal/proximal Ub respectively. (Figure 
3.7). If diagnostic c and z ions -- formed by amide bond cleavage between K63 and 
G76 (Boxed in Figure 3.7) which carry the mass of the distal (c ions) or proximal (z 
ions) Ub -- are observed the trimer is unbranched. (Figure 3.7a, b, and c) If c/z 












Figure 3.7. Visual representation of Step 3 in which fragmentation patterns of the 
endo ubiquitin are interrogated. Sites of trial additions of the proximal Ub are 
highlighted and have a ball and stick representation of the proximal Ub. For this step, 
if c or z ion fragments are seen in the green bracketed area, the chain is unbranched, 
and if there are no c or z ion fragments, it is branched. 
 
 
After the topology of the trimer is characterized as unbranched or branched, 
the linkage locations are verified in Step 4 by inspection of the fragmentation pattern 
on a topologically correct trimeric template. A simple approach, which avoids tedious 
iterative addition of one or two Ub masses at each lysine in the proximal and then 
endo moieties, is to add the appropriate mass to the N-termini (M1) and trace amide 
bond cleavage to the point where the fragmentation stops (Figure 3.8 and 3.9). Since 
the topology is known, the mass addition indicated from Step 2 on the proximal Ub 
will be one (branched) or two Ub (unbranched). For example, in the case of the Ub–
48Ub–48Ub unbranched chain, z fragmentation in the proximal moiety is observed to 




3.8a).  The absence of contradictory ions will confirm this linkage. An analogous 
approach is then applied to the endo Ub in the Ub–48Ub–48Ub example. After adding 
the mass of a monoUb to the C-terminus of the endo template, formation of ions 
assigned as z is seen not to occur beyond D52. This indicates that the endo Ub is also 
modified at K48. For confirmation, if the distal monoUb mass is added to the N-
terminus no change is observed in this z fragmentation pattern. This unique 
fragmentation is labeled in Appendix Figure 2 in the combined product ion mass 
spectrum. Despite the large masses of the modifications, this strategy is supported by 
ProSight Lite in a manner similar to the way that the mass increment of a classical     







Figure 3.8. Visual representation of Step 4, linkage determination for the endo and 
proximal moieties in chain trimers. The endo (top) and proximal (bottom) sequences 
for each unbranched chain. Sites of trial addition are highlighted in the endo Ub for 






If Step 3 indicates that the chain is branched, the linkage locations can be 
determined through a similar process. Now the proximal Ub is modified by two distal 
Ub moieties. Using the branched synthetic standard [Ub]2–
11,33Ub  as an example, 
Step 2 will already have shown a Ub addition at K33 (Figure 3.6e) due to the absence 
of z ions formed after E34. In a generalized approach, which should confirm this 
observation and find the remaining linkage, a template was constructed in which the 
mass of a monoUb is added to the N-terminus, just as in the unbranched chain 
determination, and the mass of another Ub is added to K63 (i.e. the closest linkage 
site to the C-terminus) (Figure 3.9b). The fragmentation pattern can then be used to 
determine where the c ions and z ions start and end. Again the fragmentation pattern 
shown in Figure 3.7b is consistent with the assignment of one linkage at K33, because 
in figure 3.7b, z ions are only observed before F46 and in Figure 3.9b c ions end at 
Q31. Confirming c ions are observed only after K11 in the sequence of the proximal 
ubiquitin, and the fragmentation pattern revealed by the new template localizes the 
second Ub addition at the amino terminus, at either K6 or K11.  
Using this strategy the structure of the [Ub]2–
6,48Ub trimer was 
unambiguously defined (Figure 3.9), while in the [Ub]2–
11,63Ub trimer the top-down 
strategy localized the linkage site toward the N-terminus, but could not distinguish 
K6 and K11. In the case where complete fragmentation is reported, and in the linkage 
determining step, all fragments end before K11 in the ambiguous cases, then the 
assignment at K11 would be stronger. As it is reported here, fragmentation is not 




two ambiguous cases reported here, middle-out analysis was used as a supplementary 




Figure 3.9. Visual representation of Step 4, linkage determination for the branched 
trimers. Linkage sites need to be determined only for the proximal Ub (shown). The 
site of trial addition is highlighted gold and distal moieties are represented with ball 







After all linkage sites are confirmed, a final image can be put together (Step 
5). Fragmentation density should be the highest when mapped against this final 
correct structure. Thus Step 5 provides final confirmation of the correct assignment. 

























The unbranched and branched trimers can be analyzed by acid cleavage to 
confirm the identifications made by top-down analysis. Two of the unbranched 
topologies were assumed in the top-down analysis with only one diagnostic ion in the 
K63 to G76 region. To further prove the topology as unbranched (and branched), 
MWAC can be employed, which will truncate the chains and proved further 
fragmentation. 
The ideal truncation that, like in the dimers, retains all the isopeptide linkages 
and C-termini, can be seen in Figure 3.3. The peptides produced are all cleaved on the 
distal Ub at D52 only. For the branched Ub chains, this means there are two moieties 
truncated, and for the unbranched, only one. (Figure 3.3) It was shown that, for the 
trimers to produce the ideal peptides it required 60 sec of digestion time at 140 0C and 
300 W power. (Appendix Table 3) 
Extensive fragmentation is seen in all branched (Figure 3.11) and unbranched 
(Figure 3.12) middle-out peptides. The unbranched moieties will exhibit the same 
diagnostic ions that were used to elucidate the topology in the top-down analysis. 
These fragments are boxed in green in Figure 3.11. The middle-out results confirm 
the top-down work, with even more diagnostic ions per trimer. Fragmentation for the 








Figure 3.11: Final fragmentation pattern seen for straight chain trimers of ubiquitin 
after 60 sec time-controlled acetic acid hydrolysis to produce middle-down peptides. 






MWAC could be used to resolve the sites of attachment in the branched 
trimers [Ub]2–
11,33Ub and [Ub]2–
11,63Ub. (Figure 3.12b. and c.) Truncation on only the 
distal Ubs at D52 produces a peptide that no longer produces duplicate c ions from 
the distal and proximal moieties. The c ions from the proximal moiety are unique in 
this middle-out peptide. Thus, the c and z ions seen in Figure 3.12b are unique to the 




Figure 3.12: Final fragmentation pattern seen for peptides unique to branched trimers 







Structures and functions of polyUbs are not well correlated yet, because 
polyUb modifications are difficult to decipher. This chapter suggests a robust strategy 
which provides that structural information. EThcD mass spectra of six synthetic 
ubiquitin trimers (multiply branched proteins with molecular masses exceeding 
25600Da) were examined using an orbitrap Fusion Lumos instrument to determine 
how top-down mass spectrometry could be used to characterize the trimeric chain 
topology and linkage sites in a single, facile workflow. The efficacy of this method 
relies on the formation, detection, and interpretation of extensive fragmentation. In 
cases where fragmentation is not extensive enough, middle-out methods were 
employed and resulted in complete characterization of all six isomeric chains. With 
improvements in top-down instrumentation, fragmentation should not limit this 





Chapter 4: Mass Spectrometric Analysis of Ub Tetramers 





Tetrameric ubiquitin (tetraUb) is one of the most studied linkage lengths of 
the ubiquitinome. This is partially due to its potency in early proteolysis studies 
compared to other lengths93. K63 linked tetraUb has been shown to play a role in 
antiviral signaling94 and in tumor necrosis factor (TNF) signaling95. However, studies 
are not well equipped to characterize the lengths of polyUbs present due to lack of 
methods to determine the lengths present in vivo above trimers in large proteomic 
studies.77  
TetraUb chains can form 1240 different isomers. As with all Ub chain lengths, 
each isopeptide linkage can be attached at 1 of 7 different lysines or can be linked at 
the initial methionine (M1) and the chain can comprise homogeneous or mixed 
linkages. Without considering specific linkage sites there are four general topologies 
that a tetrameric chain can take (Figure 4.1). Each of the four topologies has a 
different number of total isomers possible based on isopeptide linkage location. The 
all unbranched has 512 possible linkage combinations, the branched α-endo has 224, 
the branched proximal has 448 (from the two iterations of the dimer and monomer 







Figure 4.1. The four general topologies available to tetramers. P labels the proximal 
Ub, D the distal Ub, 1/2 is the -endo Ub, and 2 is the -endo Ub. 
 
 
To facilitate characterization by mass spectrometry the different moieties in 
the polymer must be distinguished. Traditionally the Ub with a free C-terminus is 




from the proximal Ub, or with no isopeptide linkage other than on its own C-
terminus, is known as the distal (D) moiety. Intermediate Ubs are termed endo.23,53 In 
this mass-based analysis of tetramers there are two different types of endo Ubs. The 
endo Ub attached by its C-terminus directly to a lysine on the proximal Ub is defined 
as an -endo Ub. In unbranched tetramers the -endo Ub has only the proximal mass 
attached to its C-terminus and is designated with a subscript 1 (i.e. 1-endo Ub). In 
the general case (n-endo Ub) the subscript n designates the number of Ubs attached 
directly and indirectly to the C-terminus of the endo moiety in question. The endo Ub 
attached by its C-terminus directly to a lysine on the -endo Ub is defined as a -
endo Ub.  The masses of two or three Ub moieties are attached to the -endo Ub’s C-
terminus in a tetramer. Thus it is designated with a subscript of 2 or higher (i.e. 2-









Figure 4.2. Three different topologies with the similar linkages are shown where stars 





Figure 4.2 (Continued). Three different topologies with the similar linkages are 
shown where stars highlight the unique fragments that can distinguish the topologies 
and linkages.  
 
 
 In Figure 4.2, complete fragmentation patterns for three theoretical tetramers 
are shown with all the characteristically relevant fragment ions starred. All other 
fragments are shared with the distal Ubs and thus cannot be used for structural 
determination. Unique fragmentation is not unique between topologies (the same 
colored star fragments would represent the same masses in a mass spectrum), but 




interrogated. For example, the fragments starred in gold are unique to the proximal 
Ub, but are not unique between tetramers; each proximal Ub shown has the same 
fragments starred in gold. (Figure 4.2a, b, c)  
To determine the topology of the chain, diagnostic ions (green and light blue 
stars) must be used. (Figure 4.2) Though at least one of these groups of diagnostic 
ions is present in each example tetramer, the combination of diagnostic ions changes 
depending on the orientation of the moieties. For example the spectrum represented in 
Figure 4.2a has fragment masses matching the theoretical masses of both the green 
and light blue diagnostic ions, and so can be defined as the all unbranched topology 
(also seen in Figure 4.1a). Contrastingly, figure 4.2b has only masses matching the 
diagnostic ions for the α1-endo Ub, suggesting a different structure entirely (seen in 
Figure 4.1b). Thus, different topologies can be traced by the combination of the 
diagnostic ions in green and light blue present in one tetramer study. This is 
extremely similar to the diagnostic ion strategy from the trimer analysis, but with 
more variability in topology, and another set of diagnostic ions to consider. 
Similarly to the trimer study, the ions starred in purple and dark blue map the 
linkage locations on different Ub moieties. These ions cannot be used to distinguish 
the topology of the chain nor can they alone tell which moiety they are present on. 
This is demonstrated by the fragments with purple stars, where, in Figure 4.2a the 
same mass would be mapped on the α1-endo Ub and on the proximal Ub of Figure 
4.2c.The characterization strategy presented in this chapter must employ all of these 





 The objective of the study covered in this chapter is to develop a structured 
workflow for interpreting top-down mass spectra of unanchored tetraUbs to ascertain 
the topology and linkage sites, and to test and demonstrate this approach across all 
tetramer topologies. The strategy is tested on six synthetic standards whose chemical 
structures are shown in Figure 4.3. The strategy requires extensive fragmentation 
across the branched polypeptides, provided here by electron transfer dissociation on 
an orbitrap Fusion Lumos mass spectrometer. 
 
 
Methods and Materials 
Synthesis of Ubiquitin Tetramers.  All ubiquitin tetramers were assembled 
from the respective recombinant Ub monomers using linkage-specific enzymes as 
described23,45,85,88 or, in case of [Ub]3–
6,27,48Ub, by combining this methodology with 
a nonenzymatic chain assembly approach87 by members of the Fushman laboratory. 
LC-MS/MS. Intact tetramers were diluted to 0.03 mg/mL in Solvent A 
(97.5% water, 2.5% ACN and 0.1% formic acid). The chromatography was 
performed using an Ultimate 3000 ultra-high performance liquid chromatograph 
(ThermoFisher Scientific, San Jose, CA) interfaced to a orbitrap Fusion Lumos 
Tribrid mass spectrometer (ThermoFisher Scientific). Five µL was injected, 
concentrated and desalted on a PepSwift Monolith trap (200 µm x 5 mm) for 5 min at 
99% Solvent A before separation on a ProSwift RP-4H column (100 µm x 25 cm) 
(ThermoFisher Scientific) with a gradient of 30% to 50% solvent B (75% ACN, 25% 




Precursor and fragment ion masses were acquired with a resolution of 120,000 at m/z 
200 using “intact protein mode” with 1 mtorr ion routing multipole (IRM) pressure. 
The radio frequency of the C-trap was set to 30%. Data dependent MS/MS was 
carried in top-N mode with a precursor list of m/z values calculated for each tetramer. 
Isolated parents ions were fragmented  using electron transfer dissociation 
supplemented with collisionally induced dissociation (ETciD) with a 3 msec ETD 
reaction time and supplemental activation at 10% normalized CID and averaging 20 
µscans. Reaction time was lowered compared to the dimers and trimers to 
accommodate for the increase in mass. Lower reaction times are seen to improve 
fragmentation in higher massed proteins,60  however this work saw little to no 
difference in spectra acquired with three or six msec. 
Processing the Spectra.  Precursor and fragment ions were deconvoluted 
using Xtract 3.0 (ThermoFisher Scientific). Fragment ions were matched against 
modified sequences of monoubiquitin using ProSight Lite75 with a mass tolerance 
equal to or less than 4 ppm. ProSight Lite classifies fragment ions as a,b,c,x,y and z 
and provides a probability for each modified structure based on fragmentation. 
Because our polymers contain structural redundancy an analysis of unique fragments 











Results and Discussion  
 
Six tetramers were synthesized for this study, representing the different 
topologies seen in Figure 4.1. Three unbranched tetramers were studied (Figure 4.1a), 
Ub–48Ub–48Ub–48Ub, Ub–63Ub–63Ub–63Ub and Ub–63Ub–6Ub–63Ub (with chain 
nomenclature as described in reference 23). A branched topology in which an         
1-endo Ub carries two distal Ubs, [Ub]2–
6,48Ub–48Ub, is represented in Figure 4.1b. 
Tetramer [Ub–63Ub][Ub]–6,63Ub with two isopeptide linked lysines on the proximal 
Ub is shown in Figure 4.1c. In this case one branch comprises a distal moiety and the 
other branch contains an 2-endo Ub linked to another distal unit. Finally, a tetramer 
[Ub]3–
6,27,48Ub with three distal Ubs linked to the proximal Ub was synthesized, 







Figure 4.3. Sequence and connectivity of each unbranched tetramer. From top to 
bottom tetramers presented are Ub–48Ub–48Ub–48Ub, Ub–63Ub–63Ub–63Ub, and    
Ub–63Ub–6Ub–63Ub. Residues in red represent the modified lysines. Residues in blue 
represent mutations made for the synthesis of the tetramer. Ubiquitin moieties are 
labeled with a D for distal Ub, 1 or 2 for the -endo Ubs attached to the proximal 






Figure 4.3 (Continued). Sequence and connectivity of each branched tetramer. From 
top to bottom tetramers presented are [Ub]2–
6,48Ub–48Ub, [Ub–63Ub][Ub]–6,63Ub, and              
[Ub]3–
6,27,48Ub. Residues in red represent the modified lysines. Residues in blue 
represent mutations made for the synthesis of the tetramer. Ubiquitin moieties are 
labeled with a D for distal Ub, 1 or 2 for the -endo Ubs attached to the proximal 
moiety, and P for proximal Ub. 
  
 
 The workflow presented here (Figure 4.4) extends the strategy used for 
triUbs,53 in which the monoubiquitin sequence is used as a template to assess the 
fragmentation patterns of each of the Ub moieties present in the tetramer. ProSight 
Lite allows for custom mass additions to any amino acid in the template sequence,75 




resulting fragmentation patterns are used to assign the topology of each tetramer. 
Specific linkage sites are assigned by inspection of fragmentation patterns assigned to 
each monoubiquitin template. Only c and z ions are considered on the templates, 
because b and y ions were found to introduce uninformative complexity, for example, 
miss-matching assignments corresponding to internal fragment ions.44,61  
Ubiquitin tetramers can present four different topologies, compared to two 
topologies for trimers. Thus an extra step has been incorporated to assign the tetraUb 
topology. In the case of trimers, the difference between branched and unbranched 
isomers is revealed by the presence or absence of an endo ubiquitin. In the case of the 
tetramer, three of the four potential topologies have one or two endo moieties, which 










Figure 4.4. Simplified workflow developed for interrogation of the topology and 
linkages present in ubiquitin tetramers. 
 
 
 This workflow is specific to tetrameric Ub chain lengths, and is slightly 
different from the top-down workflows reported previously for ubiquitin dimers and 
trimers. Therefore Step 1, molecular mass determination (Figure 4.4), is necessary 
before moving on to any subsequent step. The intact masses of our standard 
compounds were all confirmed as tetramers within 2 ppm mass error (Table 4.1). In 
Step 2 the spectrum is mapped onto a proximal moiety to confirm it as the spectrum 
of an unanchored polyUb with a free C-terminus. The proximal Ub can also be 
interrogated in this step to recognize the attachment site closest to the C-terminus. 
Steps 3 and 4 then test for 1-endo or 2-endo and β2-endo subunits based on 
diagnostic ions. Once the presence/absence and nature of any endo Ubs are known, a 




linkage sites are identified by inspection of the fragmentation patterns assigned to 
templates comprising each subunit with appropriate modifications (Step 5). In Step 6 




Table 4.1. The theoretical and experimental masses for each of the six isomeric 








Ub-48Ub-48Ub-48Ub 34212.44 34212.47 0.9 
Ub-63Ub-63Ub-63Ub 34184.43 34184.47 1.2 
Ub-63Ub-6Ub-63Ub 34411.48 34411.55 2 
[Ub]2-
6,48Ub-48Ub 34411.48 34411.48 0 
[Ub-63Ub,Ub]-6,63Ub 34411.48 34411.52 1.1 
[Ub]3-




 Proximal moieties with free carboxyl groups are used as templates in Step 2.  
As illustrated in Figure 4.5, fragmentation was mapped with high density for all our 
synthetic tetramers. This confirms each sample as a polyubiquitin. This fragmentation 
pattern also provides information on the site of the mass addition (linkage site) closest 
to the C-terminus just as in the previous chapters. All the z ions mapped can be 
formed only by cleavage in the unmodified portion of the proximal Ub. Based on the 
extent of formation of z ions back through the sequence, supported modified lysines 




terminus, any c ions seen here in this initial match could be redundant and cannot be 
used for sequence or topological shape information. Subsequent steps are needed to 




Figure 4.5. Matches (Step 2) of fragment ions in spectra of the proximal moiety of the 




 Step 3 is the first step in determining the topology. In this step, diagnostic ions 
are sought that are unique to any 1-endo subunits present. Such diagnostic ions are 
mapped to the region between K63 and the C-terminus when the mass of a single Ub 
has been added to the C-terminus and two Ub masses have been added to the N-
terminus as shown in Figure 4.6. The diagnostic ions are boxed in Figure 4.6. Ions 




is bonded to another Ub moiety. If there is branching on the proximal Ub, no 
fragment ions will be mapped in this region, indicating that the subunit defined as 1-
endo Ub is not present (Figure 4.6e and f).  Ions formed in any other part of the 
sequence cannot differentiate if the isopeptide linkage is on the C-terminus or on a 
lysine. (Figure 4.2) The structures that do not have the 1-endo Ub are the all 
branched [Ub]3–
6,27,48Ub (Figure 4.6f) and the branched proximal [Ub–63Ub][Ub]–




Figure 4.6. Visual representation of Step 3 in which fragment ions characteristic of an 
1-endo moiety are sought. Sites of trial additions of masses of one and two Ubs are 
highlighted, with addition of a single Ub mass at G76 and the mass of two Ubs at M1. 
At this step, if any ions are confirmed in the boxed 64-76 region, the presence of a 1-






 Step 4 is the final step needed to determine the topology of an unknown 
tetramer and it is applied to either group of tetramers defined by Step 3, tetramers 
with or without an -endo subunit. This step is similar to Step 3, but now the masses 
added to the C- and N-terminus are switched (Figure 4.7). This defines 2-endo and 
β2-endo Ub, because they have two Ub masses added to the C-terminus. By looking 
only for fragments mapped between K63 and the C-terminus, we eliminate 
contributions from isomers with different connectivity. All the tetramers expected to 
have a 2-endo or β2-endo Ub have the diagnostic ions (Figure 4.7a, b, c, and e), and 
these ions are missing in the spectra of standards that do not contain either of these 
subunits (Figure 4.7d and f). The correct diagnostic ions are detected in spectra of all 
the synthetic standards and topological classifications are achieved. Knowledge of the 
topological shape is necessary to move on to determining linkage sites since each 









Figure 4.7. Visual representation of Step 4 in which fragment ions characteristic of 
2-endo or β2-endo moieties are sought. Sites of trial additions of masses of one and 
two Ubs are highlighted, with addition of a single Ub mass (a circle) at M1 and the 
mass of two Ubs (two circles) at G76. The presence of either subunit is confirmed if c 
or z ions are found to be formed by fragmentation within the boxed region, 64-76. 
 
 
 After the topology of the tetramer is characterized, information can be sought 
about the linkage sites. One approach is to reiteratively add Ub masses at each lysine 
in the template and accept the isomer that maps the most unique fragment ions. 
Uniqueness was determined manually in this study. In a more general approach, the 
appropriate Ub masses are added to the N- and C-termini of each subunit (Figures 
4.8-4.11) and the fragmentation mapped on the correct template.  Templates of each 
subunit (carrying trial modifications dictated by topology) in each of the three 
unbranched tetramers are shown in Figure 4.8. In each panel, fragmentation can be 




modified lysine encountered. The same pattern is observed in top-down MS/MS 
spectra of ubiquitin trimers.53 As seen in Figure 4.8c this is particularly informative 
for the K6 linkage site in the 1-endo moiety of Ub–
63Ub–6Ub–63Ub. (Informative 











Figure 4.8. Linkage determination, Step 5, visualized for the unbranched tetramers. 
The tetramer and the subunits under review are identified in each panel. In the 
template for each subunit the sites of trial additions of the masses of one, two or three 








 In tetramers with branched 1-endo topology (Figure 4.1b), linkage sites must 
be determined in only two subunits, the proximal and -endo moieties. Determination 
of the linkage site on the proximal Ub proceeds analogously to that of the proximal 
moieties in the all unbranched tetramers illustrated in Figure 4.8; the mass of three Ub 
moieties is added to the N-terminus and the template is inspected for z ion formation 
from the carboxyl terminus back into the chain.  As seen in Figure 4.9b this 
fragmentation proceeds past K63 and terminates before K48. Thus the -endo Ub is 
proposed to be attached to K48 in the proximal Ub. The -endo Ub contains two 
linkage sites in this topology and must also be interrogated. Here the template is 
constructed (Figure 4.9a) by adding the mass of one distal Ub on the N-terminus, the 
mass of the proximal Ub on the C-terminus, and one Ub on K63 (the lysine closest to 
the C-terminus). Observation of a series of c ions formed by fragmentation beyond 
K6 but not in residues 1-5 locates one linkage site at K6. The combination of c ions 
and z ions localizes the second attachment to K48 or K63. In Figure 4.6d we can see 
that there is fragmentation up to K48 (c ion on G53 and z ion on R54) on the -endo 
Ub, which eliminates K63 as a possible linkage assignment, definitively allocating 







Figure 4.9. Linkage determination, Step 5, visualized for the 1-endo Ub tetramer 
[Ub]2–
6,48Ub–48Ub. Sites of trial additions are highlighted and the number of Ub 
masses added are indicated by circles. 
 
 
 In the tetramer topology group called branched proximal (Figure 4.1c) the 
proximal Ub carries two linkage sites. One of these comprises a monoUb moiety and 
the other a diUb moiety. Analysis of the proximal moiety in Step 2 (Figure 4.5c) 
clearly assigned one branch at K63. To discern whether the dimer or the monomer 
was linked at K63, dimer and monomer masses were added alternately to M1 or K63 
and the template that allowed assignment of more unique fragment ions was chosen 
as the correct orientation. This comparison is illustrated in Figures 4.10a and 4.10b, 
where it can be seen that localization of the dimer mass at the N-terminus and the 
monomer at K63 provides more fragmentation. This template also allows K6 to be 
assigned as the attachment site for diUb, distinguished by c fragmentation at G10.   
To initiate template-based analysis for the 2-endo Ub, the mass of two Ub is 




(Figure 4.10c) The fragmentation pattern supports linkage at K63, and this 




 Figure 4.10. Linkage determination, Step 5, visualized for [Ub–63Ub][Ub]–6,63Ub. 
The two proximal templates represent two isomeric structures. Trial linkage sites are 
highlighted and the number of Ub masses added are represented by circles.  
 
 
The last topological category to consider in interpreting the spectrum of an 
unknown ubiquitin tetramer is that in which the proximal Ub carries three 
monoubiquitin moieties attached at three different sites (called here the all branched 
tetramer). Examination of the template for the proximal moiety in Step 2 (Figure 4.5f) 
indicates that formation of z ions proceeds from G76 back past K63 to terminate 
before K48, indicating that K48 is a linkage site. Alternating addition of two Ubs and 
a single Ub moiety to the M1 and K63 distal Ubs (Figure 4.11a-b) provides support 




synthetic standard (K27). The absence of fragmentation suitable for this last 
assignment is confirmed when the spectrum is mapped onto the correct structure in 
Figure 4.12f. When mapped, confirming fragmentation is seen for linkages at K48 
(by Step 2 and Step 6) and K6 (by Step 5). The last moiety is limited to linkage at 
K11, K27, K29, or K33. This workflow is compatible with any future developments 




 Figure 4.11. Template maps of fragmentation in the spectrum of [Ub]3–
6,27,48Ub. a. 
and b. Trial attachment sites are highlighted and the number of ubiquitin masses 
added is shown as circles.  
 
 
After the structure of each of the synthetic standards is characterized using the 
strategy outlined above, a final evaluation is made in Step 6. In Figure 4.12 the 




from the synthetic standards. These can be compared with patterns assigned to 
incorrect structures. The correct structure should have a high fragment density and the 
highest number of unique fragments. All structures shown in Figure 4.12 yielded 




Figure 4.12. Visual representation of Step 6, in which fragmentation images are 
assigned to each of the final tetramer structures. The name of the tetramer is shown in 






Figure 4.12 (Continued). Visual representation of Step 6, in which fragmentation 
images are assigned to each of the final tetramer structures. The name of the tetramer 






Figure 4.12 (Continued). Visual representation of Step 6, in which fragmentation 
images are assigned to each of the final tetramer structures. The name of the tetramer 















 The top-down mass spectrometric workflow presented in this study correctly 
classifies Ub tetramer chains into one of four possible topologies. Assignment of the 
topology permits fragmentation to be visualized on an appropriate template and to 
allow linkage sites to be identified on each ubiquitin moiety within the chain. The 
success of the approach to interpretation of the MS/MS spectra depends on achieving 
extensive fragmentation. Sufficient fragmentation was recorded using ETciD on an 
orbitrap Fusion Lumos to assign topology to all the standards analyzed and to assign 
linkage sites in three of the four topologic groups of unanchored ubiquitin tetramers. 
The most highly branched isomer fragmented most poorly. The workflow presented 
will be even more efficient as activation techniques continue to be developed which 
provide complete fragmentation of heavy proteins. This is a workflow that can also be 
readily modified for ubiquitin-like polymers (e.g. SUMO) and mixed polymers by 
















By using the most advanced instrumentation in top-down proteomics, this 
work has provided a novel and facile strategy for mass spectral characterization of all 
polyUb chains. The location of isopeptide linkages within, and the length of, polyUb 
chains have been experimental linked to a plethora of different cellular functions. To 
determine these features, researchers have developed a multitude of different 
methods, not all of which require mass spectrometry. These methods have not been 
successful in differentiation of all possible topologies and linkages of polyUb chains. 
The lack of a facile method within the community that can differentiate all polyUb 
isomers has led to the focus of this doctoral work. 
 PolyUb chains, made of the small protein ubiquitin (Ub), are found 
throughout eukaryotic cells. Their diverse functions have been experimental linked to 
the length, linkages, and topology of the chain. To divulge the relationship between 
the chain’s features and the functions produced, labs can use only a few methods. The 
most prominent method has been to mutate the Ub chains at specific Lys residues, 
which disrupts chain formation at the mutated Lys, and report if the function being 
studied was effected. Another common method for polyUb characterization is to 
digest the chain in trypsin, resulting in peptides with a bioinformatics compatible 
search for the PTM by –GG tags at 114.043 Da. However, both these methods will 




topology of the chain. Another method was developed and is commercially available 
which divulges the length, linkage location, and to a degree, the topology by using 
deubiquitinases DUBs (UbiCRest); yet it requires completely pure sample and 
multiple experiments involving multiple DUBs. 
This work has produced a strategy which can be adapted to any fragmentation 
technique or mass analyzer that is powerful enough to produce viable results in top-
down proteomics. Outlined in the previous pages are strategies for characterizing Ub 
dimers, trimers, and tetramers. Each workflow combined was able to differentiate a 
total of 1340 possible isomers (8 from dimers, 92 from the trimers, and 1240 from the 
tetramers). The general tenet of the workflow can be applied to any chain length. The 
addition of more moieties does not hinder the strategy, in fact, additional steps can 
simply be added to the workflows presented to create a scheme for any chain length. 
In figure 5.1, a workflow is presented for pentamers, whose mass lies at the 
analytical limit of even the most advanced instrumentation in top-down proteomics. 
However, the workflow can be followed if the fragmentation is present. In an all 
unbranched pentamer linked homogenously at K48 (Figure 5.2), the instrumentation 
and methodology used for the tetramers is seen to completely characterize the 
pentaUb chain. All moieties have diagnostic ions used to characterize the unbranched 
topology (fragments seen between K63 and G76). Even at the analytical limit, the 













Figure 5.2: Final structure and fragmentation (Step 7) for Ub ̶ 48Ub ̶ 48Ub ̶ 48Ub ̶ 48Ub, 
the K48-linked unbranched Ub pentamer. Fragmentation and deconvolution was 
accomplished via the same process as the tetramers, however two parameters were 
adjusted. In this sample, 400 ng of pentamer were injected and the fragment ions were 




The method outlined in this work is applicable to any future advances in 
instrumentation and fragmentation. It could also be adapted to bioinformatics 
software to digitize this process. A workflow can be created for longer polyUbs along 
the same tenet as the examples outlined in this dissertation. At present there is no 
method which can so readily characterize polyUb chains in their entirety. Current 
research in cellular biology would greatly benefit from the advances proposed in this 
work. Definition of the ubiquitinome has the potential to outline and define the 
mechanisms at work in protein turn-over, DNA repair mechanisms, and eventually 
















Appendix Table 1. Sequences and the theoretical and observed monoisotopic masses 
of the fully truncated branched peptides analyzed from the seven all native K-linked 
diUbs. 




















































































EThcD 6 msec 
10%SA 
95 14/61/29/59 70 1/76/15/76 21 7/23/6/21 
EThcD 12msec 
10%SA 
95 12/59/35/57 77 3/74/22/75 18 6/18/6/24 
EThcD 25msec 
10%SA 
96 20/61/37/58 73 2/67/22/70 16 1/19/1/21 
       
CID 25% 81 45/0/54/2 45 24/5/61/5 10 10/0/18/0 
CID 35% 87 40/1/59/4 40 19/4/55/5 15 16/2/20/0 
CID 50% 87 28/1/61/7 29 12/0/36/5 16 18/2/22/1 
       
HCD 12% 56 27/1/37/3 37 26/7/49/1 17 25/2/18/0 
HCD 25% 84 22/1/56/4 19 7/1/22/4 10 12/0/15/3 
HCD 40% 35 10/1/15/2 3 2/1/0/2 3 0/0/8/2 
 
 
Appendix Table 3. Increase seen in the relative abundance of the desired peptide 
product for trimers from time-limited acid hydrolysis when switching from 30sec to 






















Appendix Figure 1. Fragmentation by CID observed in all fully truncated K-linked 
dimers. Linkages presented are K63 (a.), K48 (b.), K33 (c.), K29 (d.), K27 (e.), K11 
(f.), and K6 (g.). In the case of this figure only, y ions are shown in red and b ions are 








Appendix Figure 2. A representative LC-MS/MS visualized for Ub-48Ub-48Ub. The 
chromatogram is shown in a. from 8min to 27mins. Peak at 13.6 mins represents the 
elution of the trimer. The deconvoluted intact mass’s isotope cluster is shown in b. 
The top 5 m/z were deconvoluted and plotted in c. (200-6000 Da) and d. (6000-25700 




superscript P) and they represent to ions used in Step 2 to distinguish that there is a 
mass addition to K48 on the proximal ubiquitin. In blue are shown the diagnostic ions 
from the endo ubiquitin (also shown with a superscript E) which show the chain is 
unbranched in Step 3 and the ions showing the linkage is K48 on the endo ubiquitin 
















a. The chromatogram is shown from 6 min to 28 min.  
b. The deconvoluted isotope cluster of the molecular ions is plotted from 34,410-
34,455 Da.  
c. MS/MS spectrum obtained when the five most abundant isotope peaks were 





The units are the same on the two Y axes. Ions represented by peaks labeled P in red 
originate from fragmentation in the proximal ubiquitin. Peaks representing diagnostic 
ions from the 
1
-endo Ub are labeled  in blue. Peaks labeled β in purple represent 
diagnostic ions formed from cleavages in the β
2
-endo Ub. The base peak labeled M 
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